EP3368071
INNDÆLANLEGAR BÓTÚLÍN-EITURBLÖNDUR OG NOTKUNARAÐFERÐIR ÞEIRRA MEÐ MEÐFERÐAR- EÐA FEGRUNARÁHRIF TIL LANGFRAMA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.10.2016EP published:
26.1.2022EP application number:
16860952.7
EP translation filed:
26.4.2022Grant published:
15.7.2022EPO information:
European Patent Register
Max expiry date:
27.10.2036Expiry date:
27.10.2026Next due date:
31.10.2026
Title in English:
INJECTABLE BOTULINUM TOXIN FORMULATIONS AND METHODS OF USE THEREOF HAVING LONG DURATION OF THERAPEUTIC OR COSMETIC EFFECTLanguage of the patent:
English
Timeline
Today
28.10.2016EP application
26.1.2022EP Publication
26.4.2022Translation submitted
15.7.2022Registration published
27.10.2026Expires
Owner
Name:
ReVance Therapeutics, Inc.Address:
7555 Gateway Blvd., Newark, CA 94560, US
Inventor
Name:
RUEGG, Curtis L.Address:
Redwood City, California 94062, US
Name:
WAUGH, Jacob M.Address:
Palo Alto, California 94301, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201562248255 PDate:
29.10.2015Country:
US
Classification
Categories:
A61K 39/08, A61K 8/64, A61P 17/10, A61P 1/00, A61P 37/00, A61P 17/02, A61P 25/00, A61M 5/178, A61Q 19/08
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 28.7.2022
Expires: 27.10.2023
Payer: Tego IP ehf.
Number: 8
Paid: 27.10.2023
Expires: 27.10.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 24.10.2024
Expires: 27.10.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 22.10.2025
Expires: 27.10.2026
Payer: Árnason Faktor ehf.